• At A Glance
  • Education & Publications
  • Insurance
  • Profile Video

    I grew up in northern New Jersey and attended my undergraduate studies at New York University. I studied Urban Design and Architecture while also pursuing my pre-medicine studies during my undergraduate years. I received my medical degree from NYIT-College of Osteopathic Medicine followed by my pediatric residency training at Maimonides Infants and Children's Hospital of Brooklyn, where I had the opportunity to serve a culturally diverse community. I then went on to pursue a fellowship in pediatric hematology-oncology in Buffalo, NY at the highly esteemed Roswell Park Comprehensive Cancer Center and Oishei Children's Hospital Blood and Cancer Disorders Program. As a fellow at a comprehensive pediatric hematology-oncology program, I had the opportunity to treat pediatric, adolescent, and young adult patients with a wide variety of hematological and oncological diagnoses. I benefited from the training that combined an NCI Comprehensive Cancer Center, a free standing Children’s Hospital and a federally-funded comprehensive hemophilia program. I also participated in the care of children receiving a range of adoptive cellular therapies, including chimeric antigen receptor (CAR) T-cell therapies and autologous and allogeneic bone marrow transplants. While there, I pursued basic science research when joining the Ohm Lab and studied BCOR-fusion undifferentiated bone and soft tissue sarcomas and epigenetics. I have gained an appreciation for the process of translating laboratory science/results into evidence-based treatments. Prior to joining RWJBH, I was an attending physician of pediatric hematology-oncology at Mount Sinai Kravis Children's Hospital in NYC and Goryeb Children's Hospital of Morristown Medical Center in Morristown, NJ.

    Philosophy of Care:

    My philosophy of care as a pediatric hematologist-oncologist is to provide personalized, comprehensive, and family-centered care for children and their families navigating cancer and blood disorders by treating the patient, not just the disease. I want to help each patient and their families achieve as much of a sense of normalcy as possible. This approach acknowledges the unique challenge of childhood illness and strives to provide not just medical treatment, but also emotional support, education, and resources to help families cope. By building strong relationships with patients and their families through a compassionate, supportive, and holistic approach, I can foster trust and open communication which I believe is paramount.

  • Medical School

    New York Institute of Technology College of Osteopathic Medicine

    Internship

    Maimonides Infants and Children's Hospital of Brooklyn, NY

    Residency

    Maimonides Infants and Children's Hospital of Brooklyn, NY

    Fellowship

    Roswell Park Oishei Children's Cancer and Blood Disorders Program, Buffalo, NY

    Board Certification

    Pediatric-Hematology/Oncology and Pediatrics

    Publications
    • Title:CDC7 kinase (DDK) inhibition disrupts DNA replication leading to mitotic catastrophe in Ewing sarcoma. Cell Death Discov.
      Authors:
      Publisher:
      Date:
      Issue:
      Description:Martin JC, Sims JR, Gupta A, Hagoel TJ, Gao L, Lynch ML, Woloszynska A, Melendy T, Kane JF, Kuechle J, Ohm JE. Feb 2022
    • Title:Clinicopathologic and Molecular Analysis of a Single BCOR-CCNB3+ Undifferentiated Sarcoma of the Kidney Confers Significant Epigenetic Alterations. Cold Spring Harb Mol Case Stud.
      Authors:
      Publisher:
      Date:
      Issue:
      Description:Hagoel TJ, Cortez Gomez E, Gupta A, Twist CJ, Kozielski R, Martin JC, Gao L, Kuechle J, Singh PK, Lynch M, Wei L, Liu S, Wang J, Ohm JE. Nov 2021
    • Title:Exploiting Replication Stress as a Novel Therapeutic Intervention in Ewing Sarcoma. Molecular Cancer Research.
      Authors:
      Publisher:
      Date:
      Issue:
      Description:Martin JC, Hagoel TJ, Lynch, ML, Woloszynska A, Melendy T, Ohm JE. Oct 2020
    • Title:Establishing a role for environmental toxicant exposure induced epigenetic remodeling in malignant transformation. Seminars in Cancer Biology
      Authors:
      Publisher:
      Date:
      Issue:
      Description:Humphrey KM, Pandey S, Martin J, Hagoel TJ, Grand'maison A, Ohm JE. Nov 2019
  • Insurance

    Accepted Health Plan information is only as accurate as the most current information submitted. Prior to your appointment, it is advisable to verify with a physician office that they are still a participating provider.

    • Aetna
    • Aetna Better Health
    • Aetna Medicare
    • Centivo
    • CHN
    • Cigna
    • Cigna Health Springs
    • Cigna Medicare
    • Clover
    • DOL
    • Emblem
    • Fidelis (WellCare)
    • Horizon
    • Horizon Casualty
    • Horizon NJ Health
    • Humana Medicare
    • Humana Tricare
    • Longevity
    • Magnacare
    • Medicaid
    • Medicare
    • Multiplan
    • Northwell
    • QualCare
    • UHC/OX
    • UHCCP
    • US Family Health Plan
    • WellPoint (Amerigroup)